No Data
No Data
Benchmark Co. Maintains Anebulo Pharmaceuticals(ANEB.US) With Buy Rating, Maintains Target Price $8
Express News | Benchmark Reiterates Speculative Buy on Anebulo Pharmaceuticals, Maintains $8 Price Target
Anebulo Pharmaceuticals Analyst Ratings
Anebulo Pharmaceuticals | 10-K: FY2024 Annual Report
Anebulo Pharmaceuticals Reports Q4 EPS (5c) Vs. (10c) Last Year
Express News | Anebulo Pharmaceuticals, Inc. Q4 Operating Expenses USD 1.3 Million
No Data
No Data